S Goodacre1, S Dixon. 1. University of Sheffield, Sheffield, UK. s.goodacre@sheffield.ac.uk
Abstract
OBJECTIVES: The ESCAPE trial showed that chest pain observation unit (CPOU) care appeared to be cost effective compared with routine care. This finding may not be generalizable to hospitals that currently admit fewer patients than the trial hospital or that require higher direct costs to provide CPOU care. This study aimed to explore these issues in sensitivity analyses and develop a nomogram to allow prediction of whether a CPOU will be cost effective in a specific hospital. METHODS: Data from the ESCAPE trial was used to populate a decision analysis model comparing CPOU with routine care. Sensitivity analyses examined the effect of varying the admission rate with routine care and the direct running costs of CPOU care following which the nomogram was created. RESULTS: CPOU care provided improved outcome (0.3936 v 0.3799 QALYs) at lower cost (pound sterling 478 v pound sterling 556 per patient), with fewer patients admitted (37% v 54%). Mean cost of CPOU and routine care was pound sterling 116 and pound sterling 73, respectively, and of inpatient hospital stay was pound sterling 312. The mean post-discharge cost for CPOU and routine care was pound sterling 253 and pound sterling 309, respectively. Sensitivity analyses showed that CPOU care will not reduce costs at a hospital that currently admits fewer than 35% of patients, or a hospital that expects to incur direct CPOU running costs of pound sterling 60 per patient more than the trial hospital. CONCLUSIONS: Findings of the ESCAPE trial are likely to be generalizable to most settings. The nomogram presented here can be used to predict cost effectiveness in a specific hospital.
RCT Entities:
OBJECTIVES: The ESCAPE trial showed that chest pain observation unit (CPOU) care appeared to be cost effective compared with routine care. This finding may not be generalizable to hospitals that currently admit fewer patients than the trial hospital or that require higher direct costs to provide CPOU care. This study aimed to explore these issues in sensitivity analyses and develop a nomogram to allow prediction of whether a CPOU will be cost effective in a specific hospital. METHODS: Data from the ESCAPE trial was used to populate a decision analysis model comparing CPOU with routine care. Sensitivity analyses examined the effect of varying the admission rate with routine care and the direct running costs of CPOU care following which the nomogram was created. RESULTS:CPOU care provided improved outcome (0.3936 v 0.3799 QALYs) at lower cost (pound sterling 478 v pound sterling 556 per patient), with fewer patients admitted (37% v 54%). Mean cost of CPOU and routine care was pound sterling 116 and pound sterling 73, respectively, and of inpatient hospital stay was pound sterling 312. The mean post-discharge cost for CPOU and routine care was pound sterling 253 and pound sterling 309, respectively. Sensitivity analyses showed that CPOU care will not reduce costs at a hospital that currently admits fewer than 35% of patients, or a hospital that expects to incur direct CPOU running costs of pound sterling 60 per patient more than the trial hospital. CONCLUSIONS: Findings of the ESCAPE trial are likely to be generalizable to most settings. The nomogram presented here can be used to predict cost effectiveness in a specific hospital.
Authors: M E Farkouh; P A Smars; G S Reeder; A R Zinsmeister; R W Evans; T D Meloy; S L Kopecky; M Allen; T G Allison; R J Gibbons; S E Gabriel Journal: N Engl J Med Date: 1998-12-24 Impact factor: 91.245
Authors: L G Graff; J Dallara; M A Ross; A J Joseph; J Itzcovitz; R P Andelman; C Emerman; S Turbiner; J A Espinosa; H Severance Journal: Am J Cardiol Date: 1997-09-01 Impact factor: 2.778
Authors: R R Roberts; R J Zalenski; E K Mensah; R J Rydman; G Ciavarella; L Gussow; K Das; L M Kampe; B Dickover; M F McDermott; A Hart; H E Straus; D G Murphy; R Rao Journal: JAMA Date: 1997-11-26 Impact factor: 56.272
Authors: Steve Goodacre; Jon Nicholl; Simon Dixon; Elizabeth Cross; Karen Angelini; Jane Arnold; Sue Revill; Tom Locker; Simon J Capewell; Deborah Quinney; Stephen Campbell; Francis Morris Journal: BMJ Date: 2004-01-14
Authors: Felix Post; Evangelos Giannitsis; Thomas Riemer; Lars S Maier; Claus Schmitt; Burghard Schumacher; Gerd Heusch; Harald Mudra; Thomas Voigtländer; Rainer Erbel; Harald Darius; Hugo Katus; Christian Hamm; Jochen Senges; Tommaso Gori; Thomas Münzel Journal: Clin Res Cardiol Date: 2012-07-25 Impact factor: 5.460
Authors: Siegbert Stracke; Oliver Dörr; Martin C Heidt; Dursun Gündüz; Christiane Neuhof; Mariana Parahuleva; Harald Tillmanns; Ali Erdogan Journal: Clin Res Cardiol Date: 2010-05-04 Impact factor: 5.460
Authors: Frank Breuckmann; Darius G Nabavi; Felix Post; Armin J Grau; Evangelos Giannitsis; Matthias Hochadel; Jochen Senges; Otto Busse; Thomas Münzel Journal: Herz Date: 2020-09-29 Impact factor: 1.443
Authors: Bernd Nowak; Evangelos Giannitsis; Thomas Riemer; Thomas Münzel; Michael Haude; Lars S Maier; Claus Schmitt; Burghard Schumacher; Harald Mudra; Christian Hamm; Jochen Senges; Thomas Voigtländer Journal: Eur Heart J Acute Cardiovasc Care Date: 2012-12
Authors: Till Keller; Felix Post; Stergios Tzikas; Astrid Schneider; Sven Arnolds; Oliver Scheiba; Stefan Blankenberg; Thomas Münzel; Sabine Genth-Zotz Journal: Clin Res Cardiol Date: 2009-12-24 Impact factor: 5.460
Authors: Felix Post; Tommaso Gori; Evangelos Giannitsis; Harald Darius; Stephan Baldus; Christian Hamm; Rainer Hambrecht; Hans Martin Hofmeister; Hugo Katus; Stefan Perings; Jochen Senges; Thomas Münzel Journal: Clin Res Cardiol Date: 2015-07-07 Impact factor: 5.460